Article info
PDFOriginal research
Sentinel lymph node technique in early-stage ovarian cancer (SENTOV): a phase II clinical trial
- Correspondence to Dr Victor Lago, Gynecologic Oncology Department, University Hospital La Fe, Av. Fernando Abril Martorell, Tower F, 3rd Floor, 46026, Valencia, Spain; victor.lago.leal{at}hotmail.com
Citation
Sentinel lymph node technique in early-stage ovarian cancer (SENTOV): a phase II clinical trial
Publication history
- Received February 6, 2020
- Revision received March 18, 2020
- Accepted March 23, 2020
- First published May 23, 2020.
Article Versions
- Previous version (23 May 2020).
- You are currently viewing a Previous version of this article (9 June 2020).
- View the most recent version of this article
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
© IGCS and ESGO 2020. Re-use permitted under CC BY-NC. No commercial re-use. Published by BMJ. http://creativecommons.org/licenses/by-nc/4.0/This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, an indication of whether changes were made, and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/.